For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

A drug that combines a cell-killing agent with an antibody may result in remission for some patients with Hodgkin's disease and other blood cancers, according to a new clinical trial. Subscribe to ...

Weill Cornell Medicine researchers have identified that Hodgkin lymphoma cells are immune cells trapped midway between B cell and plasma cell development, unable to produce antibodies. This ...

A previously healthy 28-year-old woman was diagnosed with Hodgkin's lymphoma, nodular sclerosing type, of the neck and upper mediastinum, stage IIA. She is pregnant, 20 weeks' gestation. The neck ...

Stage 2 Hodgkin’s lymphoma is an early stage of this cancer. Healthcare professionals describe Hodgkin’s lymphoma as stage 2 when a person has cancer in two or more lymph node groups, either below or ...

Comparing Hodgkin and Non-Hodgkin Lymphoma Mortality Between Latin America and the United States From 2008 to 2019: The Need of Regional-Based Lymphoma Registries Hodgkin lymphoma (HL) is classified ...

The European Medicines Agency’s (EMA) committee on human medicines has approved extended indications for two medicines used to treat Hodgkin disease and leukemia, respectively. The drug is an antibody ...

Staging defines stage I as single nodal region or contiguous single organ involvement; PET/CT and biopsy are mandatory to localize disease and confirm histology. Clinical presentation is frequently ...